Hyperinsulinemic hypoglycemia without insulinoma: Think of activating glucokinase mutation - 26/07/18
Hypoglycémies hyperinsulinémiques sans insulinome : penser aux mutations activatrices de la glucokinase
Doi : 10.1016/j.lpm.2018.02.015
Arnaud Jannin 1, Stéphanie Espiard 1, Claire Douillard 1, 2, Florence Pasquier 3, Christine Bellanné-Chantelot 4, Marie-Christine Vantyghem 1, 5, 6, ⁎ 
1 Lille University Hospital, C. Huriez Hospital, Endocrinology and Metabolism Department, 1, rue Polonovski, 59037 Lille cedex, France
2 Lille University Hospital, Metabolic Inherited Diseases Reference Center, 59037 Lille, France
3 Lille University Hospital, Salengro Hospital, Neurology Department, 59037 Lille, France
4 Pierre-and-Marie-Curie University, Pitié-Salpêtrière Hospital, Genetic Department, 75013 Paris, France
5 INSERM U1190 Translational Research in Diabetes, 59037 Lille, France
6 E.G.I.D – FR3508 European Genomic Institute for Diabetes, 59037 Lille, France
⁎Marie-Christine Vantyghem, Endocrinology and Metabolism Department, C. Huriez Hospital, Lille University Hospital, 1, rue Polonovski, 59037 Lille cedex, France.Huriez Hospital, Lille University Hospital, 1, rue Polonovski, 59037 Lille cedex, France.
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2018
Elsevier Masson SAS. Tutti i diritti riservati.
Vol 47 - N° 6
P. 595-597 - Giugno 2018 Ritorno al numero
Articolo precedente
- Double rupture septale asymptomatique de découverte fortuite
- Hicham Mesrar, Laurent Faroux, Julia Simon, Yves-Assad Saade, Vito-Giovanni Ruggieri, Damien Metz
- Inflammation of actinic keratoses after docetaxel
- Nicolas Kluger, Leena Rentola, Petteri Hervonen, Katriina Lappalainen
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.